BDR Pharma launches generic version of Lenvatinib in India
It is indicated for the treatment of differentiated thyroid cancer, advanced liver cancer and advanced kidney cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lenvatinib
Shilpa Medicare IBRUSHIL for treatment of leukaemia
Earlier it had launched Lenvatinib ‘LENSHIL and Dasatinib ‘DASASHIL’ in the India market